Dohrn, Maike F. http://orcid.org/0000-0002-5320-9807
Medina, Jessica
Olaciregui Dague, Karmele R.
Hund, Ernst
Funding for this research was provided by:
izkf (IZKF TN1-9, 532009)
deutsche forschungsgemeinschaft (DO 2386/1-1)
Article History
Received: 15 June 2021
Accepted: 9 September 2021
First Online: 1 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: MFD received financial reimbursement for consulting and advisory board activities and travel support to attend scientific meetings by Akcea Therapeuticals Inc., Alnylam Pharmaceuticals Inc., and Pfizer Pharmaceuticals. MFD further received research funding by Pfizer Pharmaceuticals (ASPIRE 2018). JM has no conflicts. KROD has received speaker fees from Eisai GmBH. EH received financial reimbursement for consulting and advisory board activities and/or travel support by Akcea, Alnylam, and Pfizer.